Adding Pembrolizumab to Chemotherapy Increases Pathological

pCR rates improve regardless of whether patients received full chemotherapy doses.

Related Keywords

Dallas , Texas , United States , Baylor University , China , Joyce Oshaughnessy , Baylor University Medical Center , Breast Cancer Research Program , Antonio Breast Cancer Symposium , Joyceo Shaughnessy , Celebrating Women Chair , Breast Cancer Research , Baylor Charles , Cancer Center , Texas Oncology , Eastern Europe ,